G M Polyplast Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 10:27 pm

Competitors of G M Polyplast Ltd

All Competitor Stocks of G M Polyplast Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:00 am

Below is a detailed analysis of the quarterly data for G M Polyplast Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 53.29 Cr.. The value appears strong and on an upward trend. It has increased from 42.86 Cr. (Sep 2024) to 53.29 Cr., marking an increase of 10.43 Cr..
• For Expenses, as of Mar 2025, the value is 47.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 37.20 Cr. (Sep 2024) to 47.24 Cr., marking an increase of 10.04 Cr..
• For Operating Profit, as of Mar 2025, the value is 6.05 Cr.. The value appears strong and on an upward trend. It has increased from 5.66 Cr. (Sep 2024) to 6.05 Cr., marking an increase of 0.39 Cr..
• For OPM %, as of Mar 2025, the value is 11.35%. The value appears to be declining and may need further review. It has decreased from 13.21% (Sep 2024) to 11.35%, marking a decrease of 1.86%.
• For Other Income, as of Mar 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Sep 2024) to 0.02 Cr., marking a decrease of 0.04 Cr..
• For Interest, as of Mar 2025, the value is 0.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.21 Cr. (Sep 2024) to 0.32 Cr., marking an increase of 0.11 Cr..
• For Depreciation, as of Mar 2025, the value is 0.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.59 Cr. (Sep 2024) to 0.67 Cr., marking an increase of 0.08 Cr..
• For Profit before tax, as of Mar 2025, the value is 5.08 Cr.. The value appears strong and on an upward trend. It has increased from 4.92 Cr. (Sep 2024) to 5.08 Cr., marking an increase of 0.16 Cr..
• For Tax %, as of Mar 2025, the value is 24.61%. The value appears to be improving (decreasing) as expected. It has decreased from 26.42% (Sep 2024) to 24.61%, marking a decrease of 1.81%.
• For Net Profit, as of Mar 2025, the value is 3.82 Cr.. The value appears strong and on an upward trend. It has increased from 3.62 Cr. (Sep 2024) to 3.82 Cr., marking an increase of 0.20 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.84. The value appears strong and on an upward trend. It has increased from 2.69 (Sep 2024) to 2.84, marking an increase of 0.15.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:19 am

Growth

Last Updated: September 5, 2025, 3:30 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for G M Polyplast Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.53. This value is within the healthy range. It has increased from 5.27 (Mar 24) to 5.53, marking an increase of 0.26.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.53. This value is within the healthy range. It has increased from 5.27 (Mar 24) to 5.53, marking an increase of 0.26.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.47. This value is within the healthy range. It has increased from 6.22 (Mar 24) to 6.47, marking an increase of 0.25.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.12. It has increased from 23.59 (Mar 24) to 29.12, marking an increase of 5.53.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.12. It has increased from 23.59 (Mar 24) to 29.12, marking an increase of 5.53.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.00, marking a decrease of 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.44. It has increased from 68.37 (Mar 24) to 71.44, marking an increase of 3.07.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.76. This value is within the healthy range. It has increased from 8.56 (Mar 24) to 8.76, marking an increase of 0.20.
• For PBIT / Share (Rs.), as of Mar 25, the value is 7.82. This value is within the healthy range. It has increased from 7.61 (Mar 24) to 7.82, marking an increase of 0.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.42. This value is within the healthy range. It has increased from 7.33 (Mar 24) to 7.42, marking an increase of 0.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.53. This value is within the healthy range. It has increased from 5.26 (Mar 24) to 5.53, marking an increase of 0.27.
• For PBDIT Margin (%), as of Mar 25, the value is 12.25. This value is within the healthy range. It has decreased from 12.52 (Mar 24) to 12.25, marking a decrease of 0.27.
• For PBIT Margin (%), as of Mar 25, the value is 10.94. This value is within the healthy range. It has decreased from 11.13 (Mar 24) to 10.94, marking a decrease of 0.19.
• For PBT Margin (%), as of Mar 25, the value is 10.38. This value is within the healthy range. It has decreased from 10.72 (Mar 24) to 10.38, marking a decrease of 0.34.
• For Net Profit Margin (%), as of Mar 25, the value is 7.74. This value is within the healthy range. It has increased from 7.70 (Mar 24) to 7.74, marking an increase of 0.04.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.99. This value is within the healthy range. It has decreased from 22.31 (Mar 24) to 18.99, marking a decrease of 3.32.
• For Return on Capital Employeed (%), as of Mar 25, the value is 26.17. This value is within the healthy range. It has decreased from 31.11 (Mar 24) to 26.17, marking a decrease of 4.94.
• For Return On Assets (%), as of Mar 25, the value is 15.31. This value is within the healthy range. It has decreased from 17.09 (Mar 24) to 15.31, marking a decrease of 1.78.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.14. It has decreased from 2.35 (Mar 24) to 2.14, marking a decrease of 0.21.
• For Current Ratio (X), as of Mar 25, the value is 4.80. This value exceeds the healthy maximum of 3. It has increased from 3.99 (Mar 24) to 4.80, marking an increase of 0.81.
• For Quick Ratio (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 2. It has increased from 2.89 (Mar 24) to 3.17, marking an increase of 0.28.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.32. This value exceeds the healthy maximum of 8. It has increased from 7.21 (Mar 24) to 8.32, marking an increase of 1.11.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.49 (Mar 24) to 0.00, marking a decrease of 9.49.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.03 (Mar 24) to 0.00, marking a decrease of 8.03.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.51 (Mar 24) to 0.00, marking a decrease of 90.51.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.97 (Mar 24) to 0.00, marking a decrease of 91.97.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 22.07. This value is within the healthy range. It has decreased from 30.77 (Mar 24) to 22.07, marking a decrease of 8.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.94. This value is within the healthy range. It has decreased from 19.91 (Mar 24) to 14.94, marking a decrease of 4.97.
• For Enterprise Value (Cr.), as of Mar 25, the value is 110.22. It has decreased from 227.08 (Mar 24) to 110.22, marking a decrease of 116.86.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.15, marking a decrease of 1.32.
• For EV / EBITDA (X), as of Mar 25, the value is 9.35. This value is within the healthy range. It has decreased from 19.70 (Mar 24) to 9.35, marking a decrease of 10.35.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 2.48 (Mar 24) to 1.15, marking a decrease of 1.33.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 90.50 (Mar 24) to 0.00, marking a decrease of 90.50.
• For Price / BV (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has decreased from 7.18 (Mar 24) to 2.82, marking a decrease of 4.36.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 2.48 (Mar 24) to 1.15, marking a decrease of 1.33.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness